Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 13;6(6):CD002198.
doi: 10.1002/14651858.CD002198.pub3.

Local versus radical surgery for early rectal cancer with or without neoadjuvant or adjuvant therapy

M Ali K Motamedi  1 , Nicole T Mak  2 , Carl J Brown  3 , Manoj J Raval  4 , Ahmer A Karimuddin  4 , Dean Giustini  5 , Paul Terry Phang  4
Affiliations
Review

Local versus radical surgery for early rectal cancer with or without neoadjuvant or adjuvant therapy

M Ali K Motamedi et al. Cochrane Database Syst Rev. .

Abstract

Background: Total mesorectal excision is the standard of care for stage I rectal cancer. Despite major advances and increasing enthusiasm for modern endoscopic local excision (LE), uncertainty remains regarding its oncologic equivalence and safety relative to radical resection (RR).

Objectives: To assess the oncologic, operative, and functional outcomes of modern endoscopic LE compared to RR surgery in adults with stage I rectal cancer.

Search methods: We searched CENTRAL, Ovid MEDLINE, Ovid Embase, Web of Science - Science Citation Index Expanded (1900 to present), four trial registers (ClinicalTrials.gov, ISRCTN registry, the WHO International Clinical Trials Registry Platform, and the National Cancer Institute Clinical Trials database), two thesis and proceedings databases, and relevant scientific societies' publications in February 2022. We performed handsearching and reference checking and contacted study authors of ongoing trials to identify additional studies.

Selection criteria: We searched for randomized controlled trials (RCTs) in people with stage I rectal cancer comparing any modern LE techniques to any RR techniques with or without the use of neo/adjuvant chemoradiotherapy (CRT).

Data collection and analysis: We used standard Cochrane methodological procedures. We calculated hazard ratios (HR) and standard errors for time-to-event data and risk ratios for dichotomous outcomes, using generic inverse variance and random-effects methods. We regrouped surgical complications from the included studies into major and minor according to the standard Clavien-Dindo classification. We assessed the certainty of evidence using the GRADE framework.

Main results: Four RCTs were included in data synthesis with a combined total of 266 participants with stage I rectal cancer (T1-2N0M0), if not stated otherwise. Surgery was performed in university hospital settings. The mean age of participants was above 60, and median follow-up ranged from 17.5 months to 9.6 years. Regarding the use of co-interventions, one study used neoadjuvant CRT in all participants (T2 cancers); one study used short-course radiotherapy in the LE group (T1-T2 cancers); one study used adjuvant CRT selectively in high-risk patients undergoing RR (T1-T2 cancers); and the fourth study did not use any CRT (T1 cancers). We assessed the overall risk of bias as high for oncologic and morbidity outcomes across studies. All studies had at least one key domain with a high risk of bias. None of the studies reported separate outcomes for T1 versus T2 or for high-risk features. Low-certainty evidence suggests that RR may result in an improvement in disease-free survival compared to LE (3 trials, 212 participants; HR 1.96, 95% confidence interval (CI) 0.91 to 4.24). This would translate into a three-year disease-recurrence risk of 27% (95% CI 14 to 50%) versus 15% after LE and RR, respectively. Regarding sphincter function, only one study provided objective results and reported short-term deterioration in stool frequency, flatulence, incontinence, abdominal pain, and embarrassment about bowel function in the RR group. At three years, the LE group had superiority in overall stool frequency, embarrassment about bowel function, and diarrhea. Local excision may have little to no effect on cancer-related survival compared to RR (3 trials, 207 participants; HR 1.42, 95% CI 0.60 to 3.33; very low-certainty evidence). We did not pool studies for local recurrence, but the included studies individually reported comparable local recurrence rates for LE and RR (low-certainty evidence). It is unclear if the risk of major postoperative complications may be lower with LE compared with RR (risk ratio 0.53, 95% CI 0.22 to 1.28; low-certainty evidence; corresponding to 5.8% (95% CI 2.4% to 14.1%) risk for LE versus 11% for RR). Moderate-certainty evidence shows that the risk of minor postoperative complications is probably lower after LE (risk ratio 0.48, 95% CI 0.27 to 0.85); corresponding to an absolute risk of 14% (95% CI 8% to 26%) for LE compared to 30.1% for RR. One study reported an 11% rate of temporary stoma after LE versus 82% in the RR group. Another study reported a 46% rate of temporary or permanent stomas after RR and none after LE. The evidence is uncertain about the effect of LE compared with RR on quality of life. Only one study reported standard quality of life function, in favor of LE, with a 90% or greater probability of superiority in overall quality of life, role, social, and emotional functions, body image, and health anxiety. Other studies reported a significantly shorter postoperative period to oral intake, bowel movement, and off-bed activities in the LE group.

Authors' conclusions: Based on low-certainty evidence, LE may decrease disease-free survival in early rectal cancer. Very low-certainty evidence suggests that LE may have little to no effect on cancer-related survival compared to RR for the treatment of stage I rectal cancer. Based on low-certainty evidence, it is unclear if LE may have a lower major complication rate, but probably causes a large reduction in minor complication rate. Limited data based on one study suggest better sphincter function, quality of life, or genitourinary function after LE. Limitations exist with respect to the applicability of these findings. We identified only four eligible studies with a low number of total participants, subjecting the results to imprecision. Risk of bias had a serious impact on the quality of evidence. More RCTs are needed to answer our review question with greater certainty and to compare local and distant metastasis rates. Data on important patient outcomes such as sphincter function and quality of life are very limited. Results of currently ongoing trials will likely impact the results of this review. Future trials should accurately report and compare outcomes according to the stage and high-risk features of rectal tumors, and evaluate quality of life, sphincter, and genitourinary outcomes. The role of neoadjuvant or adjuvant therapy as an emerging co-intervention for improving oncologic outcomes after LE needs to be further defined.

Trial registration: ClinicalTrials.gov NCT01609504 NCT03431428 NCT02945566 NCT01308190.

PubMed Disclaimer

Conflict of interest statement

MAKM has no conflicts of interest to disclose.

NM has no conflicts of interest to disclose.

CB has no conflicts of interest to disclose.

MR has no conflicts of interest to disclose.

AK has no conflicts of interest to disclose.

DG has no conflicts of interest to disclose.

PTP has no conflicts of interest to disclose.

Figures

1
1
PRISMA flow diagram.
2
2
Risk of bias summary: review authors' judgments about each risk of bias item for each included study.
3
3
Forest plot of comparison: 1 Local excision versus radical resection, outcome: 1.1 Disease‐free survival.
4
4
Forest plot of comparison: 1 Local excision versus radical resection, outcome: 1.2 Cancer‐related survival.
5
5
Forest plot of comparison: 1 Local excision versus radical resection irrespective of chemoradiotherapy, outcome: 1.7 Major postoperative complications.
6
6
Forest plot of comparison: 1 Local excision versus radical resection irrespective of chemoradiotherapy, outcome: 1.8 Minor postoperative complications.
1.1
1.1. Analysis
Comparison 1: Local excision versus radical resection irrespective of chemoradiotherapy, Outcome 1: Disease‐free survival
1.2
1.2. Analysis
Comparison 1: Local excision versus radical resection irrespective of chemoradiotherapy, Outcome 2: Cancer‐related survival
1.3
1.3. Analysis
Comparison 1: Local excision versus radical resection irrespective of chemoradiotherapy, Outcome 3: 30‐day postoperative mortality
1.4
1.4. Analysis
Comparison 1: Local excision versus radical resection irrespective of chemoradiotherapy, Outcome 4: Major postoperative complications
1.5
1.5. Analysis
Comparison 1: Local excision versus radical resection irrespective of chemoradiotherapy, Outcome 5: Minor postoperative complications
1.6
1.6. Analysis
Comparison 1: Local excision versus radical resection irrespective of chemoradiotherapy, Outcome 6: Length of stay
1.7
1.7. Analysis
Comparison 1: Local excision versus radical resection irrespective of chemoradiotherapy, Outcome 7: Incomplete resection/conversion rate
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Bach 2020 {published data only}ISRCTN14422743
    1. Bach SP, Gilbert A, Brock K, Korsgen S, Geh I, Hill J, et al, on behalf of the TREC collaborators. Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. Lancet Gastroenterology and Hepatology 2020;2(2):92-105. [DOI: ] - PMC - PubMed
Chen 2013 {published data only}
    1. Chen Y, Liu Z, Zhu K, Shi P, Yin L. Transanal endoscopic microsurgery versus laparoscopic lower anterior resection for the treatment of T1-2 rectal cancers. Hepato-gastroenterology 2013;60(124):727-32. [DOI: ] - PubMed
Lezoche 2012 {published data only}
    1. Lezoche E, Baldarelli M, Lezoche G, Paganini AM, Gesuita R, Guerrieri M. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. British Journal of Surgery 2012;99(9):1211-8. [DOI: 10.1002/bjs.8821] - DOI - PubMed
    1. Lezoche E, Baldarelli M, Rimini M, Paganini AM, Campagnacci R, Guerrieri M. Transanal endoscopic microsurgery versus laparoscopic resections in 100 t2-n0 rectal cancers following neoadjuvant treatment: A prospective randomized trial with five years minimum follow-up. In: Surgical Endoscopy and Other Interventional Techniques. Vol. 24. 2010:S207. [DOI: ]
    1. Lezoche E, Guerrieri M, Paganini AM, D'Ambrosio G, Baldarelli M, Lezoche G, et al. Transanal endoscopic versus total mesorectal laparoscopic resections of T2-N0 low rectal cancers after neoadjuvant treatment: a prospective randomized trial with a 3-years minimum follow-up period. Surgical Endoscopy 2005;19(6):751-6. [DOI: 10.1007/s00464-004-8930-x] - DOI - PubMed
Winde 1997 {published data only}
    1. Winde G, Blasius G, Herwig R, Lugering N, Keller R, Fischer R. Benefit in therapy of superficial rectal neoplasms objectivized: transanal endoscopic microsurgery (TEM) compared to surgical standards. Minimally Invasive Therapy & Allied Technologies 1997;6(4):315-323. [DOI: 10.3109/13645709709153083] - DOI
    1. Winde G, Nottberg H, Keller R, Schmid KW, Bunte H. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Diseases of the Colon and Rectum 1996;39(9):969-76. [DOI: 10.1007/bf02054683] - DOI - PubMed
    1. Winde G, Schmid KW, Herwig R, Reers B. A safe technique for cure of superficial rectal carcinomas and adenomas: transanal endoscopic microsurgery (TEM) compared to the gold standards. In: 8th Congress of the European Society of Surgical Oncology, held at University College, Dublin, on 4-7 September 1996. Vol. 22. 1996:436.
    1. Winde G, Schmid KW, Reers B, Bunte H. Microsurgery in prospective comparison with conventional transanal excision or anterior rectum resection in adenomas and superficial carcinomas. Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress 1996;113(bad, 9200456):265-8. [PMID: ] - PubMed

References to studies excluded from this review

Ahmad 1998 {published data only}
    1. Ahmad NR, Nagle DA. Preoperative radiation therapy followed by local excision. Seminars in Radiation Oncology 1998;8(1):36-38. [DOI: 10.1016/s1053-4296(98)80035-0] - DOI - PubMed
Borstlap 2016 {published data only}
    1. Borstlap W A, Tanis P J, Koedam T W, Marijnen C A, Cunningham C, Dekker E, et al. A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer. BMC Cancer 2016;16:513. - PMC - PubMed
Bosset 2006 {published data only}
    1. Bosset J F, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. New England Journal of Medicine 2006;355(11):1114-23. - PubMed
Dewey 1985 {published data only}
    1. Dewey P, Seifart W. Transanal local treatment of early rectal cancer [Peranale lokalbehandlung des rektümfruhkarzinoms]. Zentralblatt Fur Chirurgie 1985;110(2-3):137-41. - PubMed
ISRCTN27293422 {published and unpublished data}
    1. ISRCTN27293422. The Finnish Rectal Cancer Study [A prospective randomized multicenter trial to compare the results of combined short-term preoperative radiotherapy, postoperative 5-FU based chemotherapy and total mesorectal excision with total mesorectal excision alone in the treatment of resectable rectal cancer]. www.isrctn.com/ISRCTN27293422 (first received 9 July 2012).
Luo 2005 {published data only}
    1. Luo K-Y, Shao QH, Yang GK, Mao WY, Li B, Yang R, et al. 125I seed implantation in sphincter preservation for treatment of low rectal cancer. National Medical Journal of China 2005;85(19):1355-7. - PubMed
NCT02022553 {published data only}
    1. NCT02022553. Procedure RACHEL in complex treatment of rectal cancer (RACHEL) [Complex treatment of rectal cancer]. clinicaltrials.gov/ct2/show/record/NCT02022553 (first received 30 December 2013).
NCT03548844 {published data only}
    1. NCT03548844. Local excision versus total mesorectal excision in pathological complete response (ypT0-1cN0) mid- or low-rectal cancer after neoadjuvant therapy [A prospective randomized controlled trial of local excision versus total mesorectal excision in pathological complete response (ypT0-1cN0) mid- or low-rectal cancer after neoadjuvant therapy]. clinicaltrials.gov/ct2/show/record/NCT03548844 (first received 7 June 2018).
Pontallier 2016 {published data only}
    1. Pontallier A, Denost Q, Van Geluwe B, Adam J-P, Celerier B, Rullier E. Potential sexual function improvement by using transanal mesorectal approach for laparoscopic low rectal cancer excision. Surgical Endoscopy 2016;30(11):4924-33. [DOI: 10.1007/s00464-016-4833-x] - DOI - PubMed

References to studies awaiting assessment

Rullier 2020 {published data only}
    1. Rullier E, Rouanet P, Tuech J J, Valverde A, Lelong B, Rivoire M, et al. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. The Lancet 2017;390(10093):469-79. - PubMed
    1. Rullier E, Vendrely V, Asselineau J, Rouanet P, Tuech J-J, Valverde A, et al. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial. The Lancet Gastroenterology & Hepatology 2020;5:465–74. - PubMed
    1. Rullier E, Vendrely V, Asselineau J, Rouanet P, Tuech JJ, Valverde A, et al. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial. The Lancet Gastroenterology & Hepatology 2020;5(5):465-474. [DOI: ] - PubMed

References to ongoing studies

NCT03431428 {published data only (unpublished sought but not used)}
    1. NCT03431428. Comparison of short-term efficacy and long-term prognosis for reduction surgery and radical resection in almost-cCR rectal cancer patients [Comparison of short-term efficacy and long-term prognosis for reduction surgery and radical resection in almost-cCR rectal cancer patients: a case-matched study]. clinicaltrials.gov/ct2/show/NCT03431428 (first received 13 February 2018).
Rombouts 2017 {published data only (unpublished sought but not used)}ISRCTN14240288
    1. Rombouts AJM, Al-Najami I, Abbott NL, Appelt A, Baatrup G, Bach S, et al. Can we save the rectum by watchful waiting or transanal microsurgery following (chemo) radiotherapy versus total mesorectal excision for early rectal cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study. BMJ Open 2017;7(12):e019474. [DOI: 10.1136/bmjopen-2017-019474] - DOI - PMC - PubMed
Serra Aracil 2018 {published data only (unpublished sought but not used)}
    1. Serra-Aracil X, Pericay C, Mora L, Targarona E, Delgado S, Enriquez-Navascues JM, et al. Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2-T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME). International Journal of Colorectal Disease 2018;33(2):241-9. [DOI: 10.1007/s00384-017-2942-1] - DOI - PubMed

Additional references

Akgun 2017
    1. Akgun E, Ozkok S, Tekin M, Yoldas T, Caliskan C, Kose T, et al. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study. World Journal of Surgical Oncology 2017;15:205. - PMC - PubMed
American Cancer Society 2014
    1. American Cancer Society. Colorectal cancer facts & figures 2014-2016. Atlanta: American Cancer Society, accessed at https://www.cancer.org/research/cancer-facts-statistics/colorectal-cance... 2014.
American Cancer Society 2018
    1. American Cancer Society. Cancer facts & figures 2018. Atlanta: American Cancer Society, accessed at https://www.cancer.org/research/cancer-facts-statistics/colorectal-cance... 2018.
American Joint Committee on Cancer 2017
    1. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 8th edition. New York: Springer, 2017.
Andersson 2014
    1. Andersson J, Abis G, Gellerstedt M, Angenete E, Angerås U, Cuesta M A, et al. Patient-reported genitourinary dysfunction after laparoscopic and open rectal cancer surgery in a randomized trial (COLOR II). The British Journal of Surgery 2014;101:1272-9. - PMC - PubMed
Astler 1954
    1. Astler VB, Coller FA. The prognostic significance of direct extensions of carcinoma of the colon and rectum. Annals of Surgery 1954;139(6):846-51. - PMC - PubMed
Atallah 2010
    1. Atallah S, Albert M, Larach S. Transanal minimally invasive surgery: a giant leap forward. Surgical Endoscopy 2010;24(9):2200-5. - PubMed
Bach 2009
    1. Bach SP, Hill J, Monson JR, Simson JN, Lane L, Merrie A, et al. A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. The British Journal of Surgery 2009;96(3):280-90. - PubMed
Beaton 2013
    1. Beaton C, Twine C P, Williams G L, Radcliffe A G. Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer. Colorectal Disease 2013;15(7):788-97. - PubMed
Boutron 2008
    1. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomised trials of nonpharmacologic treatment: explanation and elaboration. Annals of Internal Medicine 2008;148(4):295-309. - PubMed
Buess 1983
    1. Buess G, Theiss R, Hutterer F, Pichlmaier H, Pelz C, Holfeld T, et al. Transanal endoscopic surgery of the rectum—testing a new method in animal experiments. Leber, Magen, Darm 1983;13(2):73-7. - PubMed
Chen 2006
    1. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Annals of Surgery 2006;244(4):602-10. - PMC - PubMed
Covidence [Computer program]
    1. Covidence. Melbourne, Australia: Veritas Health Innovation, (accessed 1 April 2022). Available at www.covidence.org.
de Lacy 2018
    1. Lacy FB, Laarhoven J, Pena R, Arroyave MC, Bravo R, Cuatrecasas M, et al. Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer. Surgical Endoscopy 2018;32(5):2442-7. - PubMed
Deeks 2017
    1. Deeks JJ, Higgins JPT, Altman DG (editors) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2.
Dindo 2004
    1. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery 2004;240(2):205-13. - PMC - PubMed
Doornebosch 2007
    1. Doornebosch PG, Tollenaar RAEM, Gosselink MP, Stassen LP, Dijkhuis CM, Schouten WR, et al. Quality of life after transanal endoscopic microsurgery and total mesorectal excision in early rectal cancer. Colorectal Disease 2007;9(6):553-8. - PubMed
Doornebosch 2009
    1. Doornebosch PG, Tollenaar RA, De Graaf EJ. Is the increasing role of transanal endoscopic microsurgery in curation for T1 rectal cancer justified? A systematic review. Acta Oncologica (Stockholm, Sweden) 2009;48(3):343-53. - PubMed
D’Ambrosio 2016
    1. D’Ambrosio G, Paganini AM, Balla A, Quaresima S, Ursi P, Bruzzone P, et al. Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision. Surgical Endoscopy 2016;30(2):504-11. - PubMed
Emmertsen 2012
    1. Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Annals of Surgery 2012;255:922-8. - PubMed
Fergusson 2002
    1. Fergusson D, Aaron SD, Guyatt G, Hébert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002;325:652-4. - PMC - PubMed
Garcia‐Aguilar 2000
    1. Garcia-Aguilar J, Mellgren A, Sirivongs P, Buie D, Madoff RD, Rothenberger DA. Local excision of rectal cancer without adjuvant therapy: a word of caution. Annals of Surgery 2000;231(3):345-51. - PMC - PubMed
Garcia‐Aguilar 2015
    1. Garcia-Aguilar J, Renfro LA, Chow OS, Shi Q, Carrero XW, Lynn PB, et al. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. The Lancet Oncology 2015;16(15):1537-46. - PMC - PubMed
GLOBOCAN 2018
    1. Bray F FJ, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 2018;68(6):394-424. - PubMed
Glynne‐Jones 2017
    1. Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rodel C, Cervantes A, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2017;28:iv22-40. - PubMed
GRADE Working Group 2004
    1. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490-4. - PMC - PubMed
GRADEpro GDT [Computer program]
    1. GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime, Inc.), (accessed 1 April 2022). Available from gradepro.org.
Gujral 2007
    1. Gujral S, Conroy T, Fleissner C, Sezer O, King PM, Avery KN, et al. Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. European Journal of Cancer 2007;43:1564-73. - PubMed
Harvey 2004
    1. Harvey EH, Young MR, Flanigan TL, Carlin AM, White MT, Tyburski JG, et al. Complications are increased with the need for an abdominal-assisted Kraske procedure. The American Surgeon 2004;70(3):193-6; discussion 7. - PubMed
Heald 1982
    1. Heald RJ, Husband EM, Ryall RDH. The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? British Journal of Surgery 1982;69:613-6. - PubMed
Hendren 2005
    1. Hendren SK, O'Connor BI, Liu M, Asano T, Cohen Z, Swallow CJ, et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Annals of Surgery 2005;242:212-23. - PMC - PubMed
Herbert 2005
    1. Herbert RD, Bo K. Analysis of quality of interventions in systematic reviews. BMJ 2005;331(7515):507-9. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.
Higgins 2017
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from training.cochrane.org/handbook/archive/v5.2.
Hompes 2011
    1. Hompes R, Cunningham C. Extending the role of transanal endoscopic microsurgery (TEM) in rectal cancer. Colorectal Disease 2011;13(s7):32-6. - PubMed
Jeong 2016
    1. Jeong JU, Nam TK, Kim HR, Shim HJ, Kim YH, Yoon MS, et al. Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer. Radiation Oncology 2016;11(1):114. - PMC - PubMed
Jones 2019
    1. Jones H J S, Goodbrand S, Hompes R, Mortensen N, Cunningham C. Radiotherapy after local excision of rectal cancer may offer reduced local recurrence rates. Colorectal Disease 2019;21(4):451-9. - PubMed
Jorge 1993
    1. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Diseases of the Colon & Rectum 1993;36:77-97. - PubMed
Junginger 2016
    1. Junginger T, Goenner U, Hitzler M, Trinh T T, Heintz A, Wollschlaeger D, et al. Long-term oncologic outcome after transanal endoscopic microsurgery for rectal carcinoma. Diseases of the Colon & Rectum 2016;59(1):8-15. - PubMed
Khoo 2010
    1. Khoo RE. Transanal excision of a rectal adenoma using single-access laparoscopic port. Diseases of the Colon & Rectum 2010;53(7):1078-9. - PubMed
Kidane 2015
    1. Kidane B, Chadi S A, Kanters S, Colquhoun P H, Ott M C. Local resection compared with radical resection in the treatment of T1N0M0 rectal adenocarcinoma: a systematic review and meta-analysis. Diseases of the Colon & Rectum 2015;58(1):122-40. - PubMed
Kikuchi 1995
    1. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Diseases of the Colon & Rectum 1995;38(12):1286-95. - PubMed
Lezoche 2002
    1. Lezoche E, Guerrieri M, Paganini AM, Feliciotti F. Long-term results of patients with pT2 rectal cancer treated with radiotherapy and transanal endoscopic microsurgical excision. World Journal of Surgery 2002;26(9):1170-4. - PubMed
Lezoche 2008
    1. Lezoche G, Baldarelli M, Guerrieri M, Paganini AM, De Sanctis A, Bartolacci S, et al. A prospective randomised study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surgical Endoscopy 2008;22(2):352-8. - PubMed
Lorenz 2010
    1. Lorenz C, Nimmesgern T, Back M, Langwieler TE. Transanal single port microsurgery (TSPM) as a modified technique of transanal endoscopic microsurgery (TEM). Surgical Innovation 2010;17(2):160-3. - PubMed
Lu 2015
    1. Lu J Y, Lin G L, Qiu H Z, Xiao Y, Wu B, Zhou J L. Comparison of transanal endoscopic microsurgery and total mesorectal excision in the treatment of T1 rectal cancer: a meta-analysis. PLoS One 2015;10(10):e0141427. - PMC - PubMed
Ma 2016
    1. Ma B, Gao P, Song Y, Zhang C, Zhang C, Wang L, et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer 2016;16:380. - PMC - PubMed
Madbouly 2005
    1. Madbouly KM, Remzi FH, Erkek BA, Senagore AJ, Baeslach CM, Khandwala F, et al. Recurrence after transanal excision of T1 rectal cancer: should we be concerned? Diseases of the Colon & Rectum 2005;48(4):711-9; discussion 9-21. - PubMed
Mantel 1959
    1. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959;22:719-48. - PubMed
Mellgren 2000
    1. Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, Garcia-Aguilar J. Is local excision adequate therapy for early rectal cancer? Diseases of the Colon & Rectum 2000;43(8):1064-71; discussion 71-4. - PubMed
Moher 2009
    1. Moher D, Liberati A, Tetzlaff J, Altman D G, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 2009;6:e1000097. - PMC - PubMed
Monson 2013
    1. Monson JR, Weiser MR, Buie WD, Chang GJ, Rafferty JF, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Diseases of the Colon & Rectum 2013;56(5):535-50. - PubMed
Morino 2011
    1. Morino M, Allaix M E, Caldart M, Scozzari G, Arezzo A. Risk factors for recurrence after transanal endoscopic microsurgery for rectal malignant neoplasm. Surgical Endoscopy 2011;25:3683-90. - PubMed
Mou 2013
    1. Mou S, Soetikno R, Shimoda T, Rouse R, Kaltenbach T. Pathologic predictive factors for lymph node metastasis in submucosal invasive (T1) colorectal cancer: a systematic review and meta-analysis. Surgical Endoscopy 2013;27:2692-703. - PubMed
Nair 2008
    1. Nair RM, Siegel EM, Chen DT, Fulp WJ, Yeatman TJ, Malafa MP, et al. Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 2008;12(10):1797-805; discussion 805-6. - PubMed
Nash 2009
    1. Nash GM, Weiser MR, Guillem JG, Temple LK, Shia J, Gonen M, et al. Long-term survival after transanal excision of T1 rectal cancer. Diseases of the Colon & Rectum 2009;52(4):577-82. - PubMed
National Cancer Institute 2017
    1. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al (editors). SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. https://seer.cancer.gov/csr/1975_2014/ Bethesda, MD, based on November 2016 SEER data submission, posted to the SEER website, April 2017.
NCCN 2018
    1. Benson A B, Venook A P, Al-Hawary M M, Cederquist L, Chen Y J, Ciombor K K, et al. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 2018;16(7):874-901. - PMC - PubMed
Olsheski 2013
    1. Olsheski M, Schwartz D, Rineer J, Wortham A, Sura S, Sugiyama G, et al. A population-based comparison of overall and disease-specific survival following local excision or abdominoperineal resection for stage I rectal adenocarcinoma. Journal of Gastrointestinal Cancer 2013;44(3):305-12. - PubMed
Page 2020
    1. Page MJ, Higgins JPT, Sterne JAC. Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook/archive/v6.1.
Parikh 2019
    1. Parikh K, DeNittis AS, Marks G, Zeger E, Cho D, Marks J. Neoadjuvant chemotherapy and high-dose radiation using intensity-modulated radiotherapy followed by rectal sparing TEM for distal rectal cancer. Journal of Radiation Oncology 2019;8(2):217-24.
Parks 1968
    1. Parks AG. A technique for excising extensive villous papillomatous change in the lower rectum. Proceedings of the Royal Society of Medicine 1968;61(5):441-2. - PMC - PubMed
Parmar 1998
    1. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34. - PubMed
Ptok 2007
    1. Ptok H, Marusch F, Meyer F, Schubert D, Koeckerling F, Gastinger I, et al. Oncological outcome of local vs radical resection of low-risk pT1 rectal cancer. Archives of Surgery 2007;142:649-55; discussion 656. - PubMed
Ramirez 2000
    1. Ramirez J M, Aguilella V, Lamata F, Bielsa M A, Martinez M. Local surgical treatment in early rectal cancer with or without adjuvant therapy. Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No: CD002198. [DOI: 10.1002/14651858.CD002198] - DOI
RevMan Web 2022 [Computer program]
    1. Review Manager Web (RevMan Web). Version 4.12.0. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.
Sajid 2014
    1. Sajid M S, Farag S, Leung P, Sains P, Miles W F, Baig M K. Systematic review and meta-analysis of published trials comparing the effectiveness of transanal endoscopic microsurgery and radical resection in the management of early rectal cancer. Colorectal Disease 2014;16(1):2-14. - PubMed
Saraste 2013
    1. Saraste D, Gunnarsson U, Janson M. Predicting lymph node metastases in early rectal cancer. European Journal of Cancer 2013;49:1104-8. - PubMed
Sasaki 2017
    1. Sasaki T, Ito Y, Ohue M, Kanemitsu Y, Kobatake T, Ito M, et al. Postoperative chemoradiotherapy after local resection for high-risk T1 to T2 low rectal cancer: results of a single-arm, multi-institutional, phase II clinical trial. Diseases of the Colon & Rectum 2017;60:914-21. - PMC - PubMed
Schünemann 2011
    1. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.
Serra‐Aracil 2008
    1. Serra-Aracil X, Vallverdu H, Bombardo-Junca J, Pericay-Pijaume C, Urgelles-Bosch J, Navarro-Soto S. Long-term follow-up of local rectal cancer surgery by transanal endoscopic microsurgery. World Journal of Surgery 2008;32:1162-7. - PubMed
Sgourakis 2011
    1. Sgourakis G, Lanitis S, Gockel I, Kontovounisios C, Karaliotas C, Tsiftsi K, et al. Transanal endoscopic microsurgery for T1 and T2 rectal cancers: a meta-analysis and meta-regression analysis of outcomes. Amercian Surgeon 2011;77(6):761-72. - PubMed
Shaikh 2015
    1. Shaikh I, Askari A, Ouru S, Warusavitarne J, Athanasiou T, Faiz O. Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis. International Journal of Colorectal Disease 2015;30(1):19-29. - PubMed
Sylla 2010
    1. Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surgical Endoscopy 2010;24(5):1205-10. - PubMed
The EuroQol Group 1990
    1. The EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208. - PubMed
Thorlund 2011 [Computer program]
    1. User manual for trial sequential analysis (TSA). Thorlund K, Engstrom J, Wetterslev J, Brok J, Imberger G, Gluud C. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark, 2011.
Tierney 2007
    1. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16. - PMC - PubMed
Verseveld 2015
    1. Verseveld M, Graaf E J, Verhoef C, Meerten E, Punt C J, Hingh I H, et al. Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study). British Journal of Surgery 2015;102(7):853-60. - PubMed
Vogel 2017
    1. Vogel JD, Eskicioglu C, Weiser MR, Feingold DL, Steele SR. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the treatment of colon cancer. Diseases of the Colon & Rectum 2017;60(10):999-1017. - PubMed
Wang 2018
    1. Wang XJ, Chi P, Zhang YY, Lin HM, Lu XR, Huang Y, et al. Survival outcome of adjuvant radiotherapy after local excision for T2 early rectal cancer: An analysis based on the surveillance, epidemiology, and end result registry database. European Journal of Surgical Oncology 2018;44(12):1865-72. - PubMed
Ware 1992
    1. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992;30(6):473-483. - PubMed
Wawok 2018
    1. Wawok P, Polkowski W, Richter P, Szczepkowski M, Oledzki J, Wierzbicki R, et al. Preoperative radiotherapy and local excision of rectal cancer: Long-term results of a randomised study. Radiotherapy and Oncology 2018;127(3):396-403. - PubMed
Winde 1996
    1. Winde G, Nottberg H, Keller R, Schmid KW, Bunte H. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Diseases of the Colon & Rectum 1996;39(9):969-76. - PubMed
Wrenn 2018
    1. Wrenn SM, Cepeda-Benito A, Ramos-Valadez DI, Cataldo PA. Patient perceptions and quality of life after colon and rectal surgery: what do patients really want? Diseases of the Colon & Rectum 2018;61:971-8. - PubMed
Xu 2017
    1. Xu ZS, Cheng H, Xiao Y, Cao JQ, Cheng F, Xu WJ, et al. Comparison of transanal endoscopic microsurgery with or without neoadjuvant therapy and standard total mesorectal excision in the treatment of clinical T2 low rectal cancer: a meta-analysis. Oncotarget 2017;8(70):115681-90. - PMC - PubMed
You 2007
    1. You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Annals of Surgery 2007;245:726-33. - PMC - PubMed

References to other published versions of this review

Borao 2011
    1. Borao E, Ramirez J M, Gracia J A, Aguilella V, Martinez M, Maeso‐Martínez S, et al. Local surgical treatment in early rectal cancer with or without adjuvant therapy. Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No: CD002198. [DOI: 10.1002/14651858.CD002198.pub2] - DOI

Publication types

Associated data